Status:
UNKNOWN
Clinical Outcome of Extended-depth-of-focus Intraocualr Lens (SAV) Implantation
Lead Sponsor:
Samsung Medical Center
Conditions:
Presbyopia
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Clinical outcome of extended-depth-of-focus intraocular lens (SAV) implantation
Detailed Description
In this study, we are trying to evaluate the clinical outcome of extended-depth-of-focus intraocular lens (SAV).
Eligibility Criteria
Inclusion
- Adult at the age of 21 or older at the time of the pre-operative examination and willing to have surgery on their 2nd eye within 7-28 days of their 1st eye
- Age-related cataract
- A patient with preoperative corneal astigmatism from IOL Master less than 1 diopters
- A patient want presbyopia correction at the same time as cataract surgery
- A patient has the visual potential of 20/25 or better in each eye after cataract removal and IOL implantation
- Written informed consent to surgery and participation in the study
Exclusion
- Those with other diseases that can affect capsule stability such as pseudoexoliation syndrome, glaucoma, traumatic cataract
- Pregnant woman and lactating woman
- A patient with history of ocular trauma or ocular surgery (Intraocular surgery, refractive surgery, ocular surface surgery) in either eye
- A patient with evidence of keratoconus or significant irregular astigmatism on pre-operative topography in either eye
- If expectations for presbyopia correction are too high
- Those who are not able to read and understand the informed consent (illiterate or foreigners)
Key Trial Info
Start Date :
February 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 22 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04391972
Start Date
February 11 2020
End Date
January 22 2021
Last Update
May 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea